BackRecursion Pharmaceuticals Overview

Recursion Pharmaceuticals Gross Profit

Gross Profit analysis for RXRX.

Quarterly Gross Profit

$-6018000.00
↓ 15.05% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$-7926000.00
↓ 305.66% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin